These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
188 related articles for article (PubMed ID: 29893296)
1. End of the road for terbinafine? Results of a pragmatic prospective cohort study of 500 patients. Singh S; Shukla P Indian J Dermatol Venereol Leprol; 2018; 84(5):554-557. PubMed ID: 29893296 [TBL] [Abstract][Full Text] [Related]
2. Limited effectiveness of four oral antifungal drugs (fluconazole, griseofulvin, itraconazole and terbinafine) in the current epidemic of altered dermatophytosis in India: results of a randomized pragmatic trial. Singh S; Chandra U; Anchan VN; Verma P; Tilak R Br J Dermatol; 2020 Nov; 183(5):840-846. PubMed ID: 32538466 [TBL] [Abstract][Full Text] [Related]
3. Efficacy and tolerability of topical sertaconazole versus topical terbinafine in localized dermatophytosis: A randomized, observer-blind, parallel group study. Chatterjee D; Ghosh SK; Sen S; Sarkar S; Hazra A; De R Indian J Pharmacol; 2016; 48(6):659-664. PubMed ID: 28066103 [TBL] [Abstract][Full Text] [Related]
6. Efficacy and safety of 250 mg versus 500 mg oral terbinafine in the treatment of tinea corporis and cruris: A randomised, assessor-blinded comparative study. Lal NR; Basu D; Saha A; Ghosh R; Verma R; Bandyopadhyay D Indian J Dermatol Venereol Leprol; 2023; 89(5):665-671. PubMed ID: 36688883 [TBL] [Abstract][Full Text] [Related]
7. Once daily treatment with terbinafine 1% cream (Lamisil) for one week is effective in the treatment of tinea corporis and cruris. A placebo-controlled study. Budimulja U; Bramono K; Urip KS; Basuki S; Widodo G; Rapatz G; Paul C Mycoses; 2001; 44(7-8):300-6. PubMed ID: 11714065 [TBL] [Abstract][Full Text] [Related]
8. Efficacy of oral terbinafine versus itraconazole in treatment of dermatophytic infection of skin - A prospective, randomized comparative study. Bhatia A; Kanish B; Badyal DK; Kate P; Choudhary S Indian J Pharmacol; 2019; 51(2):116-119. PubMed ID: 31142947 [TBL] [Abstract][Full Text] [Related]
9. A comparative double-blind study of terbinafine (Lamisil) and griseofulvin in tinea corporis and tinea cruris. del Palacio Hernandez A; López Gómez S; González Lastra F; Moreno Palancar P; Iglesias Díez L Clin Exp Dermatol; 1990 May; 15(3):210-6. PubMed ID: 2194715 [TBL] [Abstract][Full Text] [Related]
10. Comparative study between terbinafine 1% emulsion-gel versus ketoconazole 2% cream in tinea cruris and tinea corporis. Bonifaz A; Saúl A Eur J Dermatol; 2000 Mar; 10(2):107-9. PubMed ID: 10694308 [TBL] [Abstract][Full Text] [Related]
11. One-week therapy with oral terbinafine in cases of tinea cruris/corporis. Farag A; Taha M; Halim S Br J Dermatol; 1994 Nov; 131(5):684-6. PubMed ID: 7999601 [TBL] [Abstract][Full Text] [Related]
12. Safety and efficacy of short-duration oral terbinafine for the treatment of tinea corporis or tinea cruris in subjects with HIV infection or diabetes. Rich P; Houpt KR; LaMarca A; Loven KH; Marbury TC; Matheson R; Miller B; Smith S; Wolf J; Cutis; 2001 Jul; 68(1 Suppl):15-22. PubMed ID: 11499330 [TBL] [Abstract][Full Text] [Related]
13. Open clinical study of the efficacy and safety of terbinafine cream 1% in children with tinea corporis and tinea cruris. Bakos L; Brito AC; Castro LC; Gontijo B; Lowy G; Reis CM; Ribeiro AM; Souza FH; Villar Mdo L; Zaitz C Pediatr Infect Dis J; 1997 Jun; 16(6):545-8. PubMed ID: 9194102 [TBL] [Abstract][Full Text] [Related]
14. Efficacy and safety of terbinafine 1% solution in the treatment of interdigital tinea pedis and tinea corporis or tinea cruris. Lebwohl M; Elewski B; Eisen D; Savin RC Cutis; 2001 Mar; 67(3):261-6. PubMed ID: 11270304 [TBL] [Abstract][Full Text] [Related]
15. Relapse after Oral Terbinafine Therapy in Dermatophytosis: A Clinical and Mycological Study. Majid I; Sheikh G; Kanth F; Hakak R Indian J Dermatol; 2016; 61(5):529-33. PubMed ID: 27688443 [TBL] [Abstract][Full Text] [Related]
16. [Terbinafine resistance explains treatment failure in a patient with tinea corporis]. Buil JB; Bronckers IMGJ; Driessen RJB; Do Nguyen Dan T; Melchers WJG; Verweij PE Ned Tijdschr Geneeskd; 2021 Nov; 165():. PubMed ID: 35129895 [TBL] [Abstract][Full Text] [Related]
17. Etiological prevalence and antifungal sensitivity patterns of dermatophytosis in India - A multicentric study. Tahiliani S; Saraswat A; Lahiri AK; Shah A; Hawelia D; Shah GK; Girdhar M; Rao PN; Raghav PA; Agarwal P; Kharkar RD; Gupta RP; Udare S; Hegde S; Haldar S Indian J Dermatol Venereol Leprol; 2021; 87(6):800-806. PubMed ID: 34160163 [TBL] [Abstract][Full Text] [Related]
18. Oral treatment of tinea corporis and tinea cruris with terbinafine and griseofulvin: a randomized double blind comparative study. Voravutinon V J Med Assoc Thai; 1993 Jul; 76(7):388-93. PubMed ID: 8089640 [TBL] [Abstract][Full Text] [Related]
19. Efficacy and Safety of Terbinafine Hydrochloride 1% Cream vs. Sertaconazole Nitrate 2% Cream in Tinea Corporis and Tinea Cruris: A Comparative Therapeutic Trial. Choudhary S; Bisati S; Singh A; Koley S Indian J Dermatol; 2013 Nov; 58(6):457-60. PubMed ID: 24249898 [TBL] [Abstract][Full Text] [Related]
20. Terbinafine. An update of its use in superficial mycoses. McClellan KJ; Wiseman LR; Markham A Drugs; 1999 Jul; 58(1):179-202. PubMed ID: 10439936 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]